The restoration
of balance


Resokine Pathway Discovery Pre-clinical Phase 1 Phase 2 Phase 3
ATYR1923 (iMod.Fc)
Interstitial Lung Disease
Various Cancers
ATYR1940 (Resolaris™)
Rare Muscular Dystrophies
tRNA Sythetase Pipeline Discovery Pre-clinical Phase 1 Phase 2 Phase 3
Multiple Discovery Programs

  • Internal Programs at aTyr
  • The Scripps Research Institute
  • Hong Kong University of Science and Technology


Therapeutic Focus Phase
Resokine Pathway / Muscle
Resolaris for Adult FSHD Phase 1b/2
Resolaris for Early Onset FHSD Phase 1b/2
Resolaris for Adult LGMD2B Phase 1b/2
Resokine Pathway / Lung
iMod.Fc for Rare Lung Disease Pre-clinical
Resokine Pathway / Cancer
Project ORCA Pre-clinical
Physiocrine R&D

We intend to leverage our unique understanding of extracellular tRNA synthetase biology and our broad intellectual property portfolio, which we believe covers this entire class of potential protein therapeutics, to build a pipeline of product candidates that we expect to develop and commercialize independently for the treatment of various rare diseases.

© 2007 - 2018   aTyr Pharma.   Legal   Privacy Policy